Procept BioRobotics Corp (NASDAQ:PRCT) price on Friday, April 11, rose 2.64% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $52.07.
A look at the stock’s price movement, the close in the last trading session was $50.73, moving within a range at $49.03 and $52.5. The beta value (5-Year monthly) was 1.085. Turning to its 52-week performance, $103.81 and $47.04 were the 52-week high and 52-week low respectively. Overall, PRCT moved -7.07% over the past month.
Procept BioRobotics Corp’s market cap currently stands at around $2.85 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-24.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PRCT is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend PRCT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
PRCT’s current price about -8.14% and -15.64% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 40.13, while 7-day volatility ratio is 11.04% and 6.32% in the 30-day chart. Further, Procept BioRobotics Corp (PRCT) has a beta value of 1.14, and an average true range (ATR) of 4.07. Analysts have given the company’s stock an average 52-week price target of $105, forecast between a low of $105 and high of $105. Looking at the price targets, the low is -101.65% off current price level while to achieve the yearly target high, price needs to move -101.65%. Nonetheless, investors will most likely welcome a -101.65% jump to $105 which is the analysts’ median price.
If we refocus on Procept BioRobotics Corp (NASDAQ:PRCT), historical trading data shows that trading volumes averaged 1.14 over the past 10 days and 1.01 million over the past 3 months. The company’s latest data on shares outstanding shows there are 54.72 million shares.
The 5.37% of Procept BioRobotics Corp’s shares are in the hands of company insiders while institutional holders own 92.18% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.83 million on 2025-03-14, giving us a short ratio of 5.19. The data shows that as of 2025-03-14 short interest in Procept BioRobotics Corp (PRCT) stood at 1432.0 of shares outstanding, with shares short rising to 5.68 million registered in 2025-02-14. Current price change has pushed the stock -35.33% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PRCT stock continues to rise going into the next quarter.
